欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Purevax RC
适用类别Veterinary
治疗领域
通用名/非专利名称vaccine against feline viral rhinotracheitis and feline calicivirosis
活性成分attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains)
产品号EMEA/V/C/000091
患者安全信息no
授权状态Authorised
ATC编码
是否额外监管no
是否仿制药no
是否生物类似药no
是否附条件批准no
是否特殊情形no
是否加速审评no
是否罕用药no
批准上市日期2005/02/23
上市许可持有人/公司名称Boehringer Ingelheim Vetmedica GmbH
兽用药物治疗分组Immunologicals for felidae,
审评意见发布日期2004/11/10
决定日期2022/02/17
修订号16
适应症Active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs.Onsets of immunity isone week after primary vaccination course.The duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.
适用物种Cats
兽用药物ATC编码QI06AH08
首次发布日期2015/01/15
修订日期2022/03/29
产品信息https://www.ema.europa.eu/en/documents/product-information/purevax-rc-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/purevax-rc
©2006-2024 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase